[1] Chinese Society of Hepatology, Chinese Medical Asso, Chinese Society of Infectious Diseases, Chinese Med. The guideline of prevention and treatment for hepatitis C: a 2015 update. Chin J Hepatol 2015;23(12):906 − 23. http://dx.doi.org/10.3760/cma.j.issn.1007-3418.2015.12.003 (In Chinese)CrossRef
[2] Zhu P. Progress in the study of mixed infection of HIV and HCV and its treatment. Chin J Clin Rational Drug Use 2012;5(20):174 − 5. http://dx.doi.org/10.3969/j.issn.1674-3296.2012.20.146 (In Chinese)CrossRef
[3] Qin QQ, Smith MK, Wang L, Su YY, Wang LY, Guo W, et al. Hepatitis C virus infection in China: an emerging public health issue. J Viral Hepat 2015;22(3):238 − 44. http://dx.doi.org/10.1111/jvh.12295CrossRef
[4] Hei FX, Ye SD, Ding GW, Pang L, Wang XC, Liu ZF. Epidemiological analysis on reported hepatitis C cases in China from 2012 to 2016. Biomed Environ Sci 2018;31(10):773 − 6. http://dx.doi.org/10.3967/bes2018.103CrossRef
[5] National Health and Family Planning Commission of PRC. WS 213-2018 diagnosis for hepatitis C. Chin J Hepatol 2018;34(8):1619 − 21. http://dx.doi.org/10.3969/j.issn.1001-5256.2018.08.006 (In Chinese)CrossRef
[6] Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001;34(4):809 − 16. http://dx.doi.org/10.1053/jhep.2001.27831CrossRef
[7] Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 2006;3(2):47 − 52. http://dx.doi.org/10.7150/ijms.3.47CrossRef
[8] National Health and Family Planning Commission, National Development and Reform Commission, Ministry of Education, Ministry of Science and Technology, Ministry of Industry and Information Technology, Ministry of Public Security, et al. China viral hepatitis prevention and control plan (2017-2020). Chin J Viral Dis 2018;8(1):1 − 5. http://dx.doi.org/10.16505/j.2095-0136.2018.0001 (In Chinese)CrossRef